By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cypress Bioscience Inc. 

4350 Executive Drive, Suite 325

San Diego  California  92121  U.S.A.
Phone: 858-550-6042 Fax: n/a


Cypress is a pharmaceutical company dedicated to the development of innovative drugs targeting large unmet medical needs for patients suffering from a variety of disorders of the central nervous system. Since 1999, Cypress has received FDA approvals for both of the products it brought to the FDA during that period, including for Prosorba™, a medical device for rheumatoid arthritis, and Savella® (milnacipran HCl), for fibromyalgia. The Company focuses on generating stockholder value by reaching clinical development milestones as quickly and efficiently as possible. Cypress’ development-stage assets include CYP-1020 for cognitive impairment in schizophrenia, Staccato® nicotine for smoking cessation and intranasal carbetocin for autism. More information on Cypressand its products and development assets is available at

Key Statistics

Ownership: Public

Web Site: Cypress Bioscience Inc.
Employees: 36
Symbol: CYPB


Company News
New Cypress Bioscience Inc. (CYPB) Owners Oust Besieged CEO 1/28/2011 10:22:56 AM
BioLineRx Ltd. Announces Cypress Bioscience Inc. (CYPB)'s and Royalty Pharma's Commitment to the Development of BL-1020 (CYP-1020) Program 1/25/2011 10:37:49 AM
Ramius and Royalty Pharma Announce Successful Conclusion of Cypress Bioscience Inc. (CYPB) Tender Offer 1/6/2011 7:35:26 AM
Cypress Bioscience Inc. (CYPB) Release: Federal Trade Commission Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act 1/4/2011 9:06:52 AM
Cypress Bioscience Inc. (CYPB) Agrees To Be Bought By Ramius For Raised $255M Bid 12/15/2010 7:01:57 AM
Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience Inc. (CYPB) for $5.50 Per Share 12/10/2010 7:40:23 AM
Cypress Bioscience Inc. (CYPB) Announces Third Quarter 2010 Financial Results 11/9/2010 11:09:16 AM
Cypress Bioscience Inc. (CYPB) to Present at Oppenheimer 21st Annual Healthcare Conference 11/3/2010 8:55:13 AM
Cypress Bioscience Inc. (CYPB) Sells Diagnostics Business Exagen Diagnostics, Inc. for up to $8 Million 10/11/2010 7:28:43 AM
Cypress Bioscience Inc. (CYPB) Rejects Raised Ramius Bid, May Sell Assets or Entire Company 9/28/2010 7:23:24 AM